Tocilizumab Pen 162 mg/0.9 mL, 80 mg/0.4 mL Suppliers & Bulk Manufacturers
Available Forms: Pre-filled Syringe or Pen
Available Strengths: 162 mg/0.9 mL, 80 mg/0.4 mL
Reference Brands: Actemra (US & EU)
Category: Arthritis
Tocilizumab pen inhibits IL-6 receptor activity, reducing inflammation and immune response in rheumatoid arthritis. Benefits include rapid symptom relief, improved joint function, and disease activity reduction. Its convenient subcutaneous pen device enhances patient adherence and quality of life, making it an effective,easy-to-use biologic therapy for autoimmune conditions.
Product Description: Tocilizumab pen is approved in the EU and US for rheumatoid arthritis and other autoimmune diseases. In the EU, brands like RoActemra are regulated by EMA, supported by dossiers demonstrating safety, efficacy, and quality. In the US, FDA approval is based on extensive clinical data, biosimilarity, and pharmacovigilance. Both regions require detailed dossiers for initial approval and ongoing safety monitoring. For expert assistance with regulatory dossiers, compliance, and registration, visit PharmaTradz. We support efficient market access for tocilizumab pens, ensuring adherence to European and American standards for safe, effective biologic therapy, helping you navigate complex regulatory processes seamlessly.
Tocilizumab Pen — third party manufacturing & bulk supply
Tocilizumab Pen 162 mg/0.9 mL, 80 mg/0.4 mL is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:
What to include when you enquire
- Destination market — determines which manufacturers hold the right site-level approvals
- First order quantity and estimated annual volume
- Whether you need a registration dossier or the product is already registered
- Packaging, labelling and language requirements
- Incoterms and required shelf life
Indicative minimum order quantity
Tocilizumab Pen is supplied as Pre-filled Syringe or Pen — an injectable dosage form, so the indicative MOQ is 50,000 units. Actual MOQ is confirmed by the allocated manufacturer against your pack presentation and destination market. See full supply terms for dossier formats, market availability and shelf life.
Manufacturers of Tocilizumab Pen listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding. Narcotic drugs and controlled substances are supplied strictly against valid import and export permits issued by the competent authorities.
Request a quote for Tocilizumab Pen →The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Frequently Asked Questions
Related Products
Pegloticase Injecatble
Strength:
8 mg/1.2 mL vial
Form: Injectable (IV solution)
Reference Brands: Krystexxa (US)
View Details
Febuxostat Tablets
Strength:
40 mg, 80 mg
Form: Oral Tablets
Reference Brands: Uloric(EU & US)
View Details
Allopurinol Tablets
Strength:
100 mg, 300 mg
Form: Oral Tablets
Reference Brands: Aloprim(US & EU)
View DetailsQuick Response Guaranteed | Verified Suppliers
